Physician profile
Mario G Gasparri
NPI 1114971439
$516,109.60
in general payments reported to CMS, 2019-2025
12 companies · $120K in 2025
The $120K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67K · 2020: $38K · 2021: $73K · 2022: $59K · 2023: $46K · 2024: $112K · 2025: $120K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $226K · Travel and Lodging: $22K · Education: $15K · Food and Beverage: $8,261 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000 · Honoraria: $3,461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $225,750.00 |
| Travel and Lodging | $22,118.20 |
| Education | $14,500.00 |
| Food and Beverage | $8,261.44 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
| Honoraria | $3,460.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $355,122.73 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System, Epi-Sense Guided Coagulation System With Visitrax, Atricure Cryoice Cryoablation System (Cryo2) |
| Intuitive Surgical, INC. | $91,025.08 | 2019-2025 | Da Vinci Surgical System |
| Synthes Gmbh | $34,946.25 | 2019-2023 | |
| Medical Device Business Services, INC. | $33,896.42 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $456.30 | 2020-2021 | |
| On Target Laboratories, INC | $226.91 | 2025 | Cytalux |
| Enduromed, LLC | $108.80 | 2024 | |
| Synthes USA Products LLC | $100.34 | 2020 | |
| Elutia, INC. | $79.31 | 2023 | |
| Baxter Healthcare | $78.24 | 2024 | Perclot |
| Hemosonics LLC | $50.22 | 2024 | Quantra Qplus System, Qunatra Qplus System |
| Depuy Synthes Sales INC. | $19.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Gasparri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.